Charles J Dockendorff - Net Worth and Insider Trading

Charles J Dockendorff Net Worth

The estimated net worth of Charles J Dockendorff is at least $17 Million dollars as of 2024-11-08. Charles J Dockendorff is the Director of Keysight Technologies Inc and owns about 52,423 shares of Keysight Technologies Inc (KEYS) stock worth over $9 Million. Charles J Dockendorff is the Director of Boston Scientific Corp and owns about 60,002 shares of Boston Scientific Corp (BSX) stock worth over $5 Million. Charles J Dockendorff is also the Director of Haemonetics Corp and owns about 20,141 shares of Haemonetics Corp (HAE) stock worth over $2 Million. Besides these, Charles J Dockendorff also holds Hologic Inc (HOLX) . Details can be seen in Charles J Dockendorff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles J Dockendorff has not made any transactions after 2024-05-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Charles J Dockendorff

To

Charles J Dockendorff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles J Dockendorff owns 4 companies in total, including Haemonetics Corp (HAE) , Boston Scientific Corp (BSX) , and Keysight Technologies Inc (KEYS) among others .

Click here to see the complete history of Charles J Dockendorff’s form 4 insider trades.

Insider Ownership Summary of Charles J Dockendorff

Ticker Comapny Transaction Date Type of Owner
HAE Haemonetics Corp 2023-09-05 director
BSX Boston Scientific Corp 2024-05-07 director
KEYS Keysight Technologies Inc 2022-12-13 director
LIMIT LIMIT 2024-03-08 director

Charles J Dockendorff Latest Holdings Summary

Charles J Dockendorff currently owns a total of 4 stocks. Among these stocks, Charles J Dockendorff owns 52,423 shares of Keysight Technologies Inc (KEYS) as of December 13, 2022, with a value of $9 Million and a weighting of 51.06%. Charles J Dockendorff owns 60,002 shares of Boston Scientific Corp (BSX) as of May 7, 2024, with a value of $5 Million and a weighting of 30.74%. Charles J Dockendorff also owns 20,141 shares of Haemonetics Corp (HAE) as of September 5, 2023, with a value of $2 Million and a weighting of 10.28%. The other 1 stocks Hologic Inc (HOLX) have a combined weighting of 7.92% among all his current holdings.

Latest Holdings of Charles J Dockendorff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KEYS Keysight Technologies Inc 2022-12-13 52,423 165.18 8,659,231
BSX Boston Scientific Corp 2024-05-07 60,002 86.88 5,212,974
HAE Haemonetics Corp 2023-09-05 20,141 86.53 1,742,801
HOLX Hologic Inc 2024-03-08 16,942 79.29 1,343,331

Holding Weightings of Charles J Dockendorff


Charles J Dockendorff Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 1 transactions in Keysight Technologies Inc (KEYS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Keysight Technologies Inc is the sale of 3,257 shares on December 13, 2022, which brought Charles J Dockendorff around $602,740.

According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 2 transactions in Boston Scientific Corp (BSX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Boston Scientific Corp is the sale of 3,946 shares on May 7, 2024, which brought Charles J Dockendorff around $286,874.

According to the SEC Form 4 filings, Charles J Dockendorff has made a total of 2 transactions in Haemonetics Corp (HAE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Haemonetics Corp is the sale of 10,215 shares on September 5, 2023, which brought Charles J Dockendorff around $895,651.

More details on Charles J Dockendorff's insider transactions can be found in the Insider Trading History of Charles J Dockendorff table.

Insider Trading History of Charles J Dockendorff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles J Dockendorff Trading Performance

GuruFocus tracks the stock performance after each of Charles J Dockendorff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles J Dockendorff is 14.28%. GuruFocus also compares Charles J Dockendorff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles J Dockendorff within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles J Dockendorff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles J Dockendorff

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.71 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.09 LIMIT LIMIT LIMIT LIMIT LIMIT

Charles J Dockendorff Ownership Network

Ownership Network List of Charles J Dockendorff

No Data

Ownership Network Relation of Charles J Dockendorff

Insider Network Chart

Charles J Dockendorff Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Charles J Dockendorff is the director of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP and General Counsel Michelle L Basil .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Charles J Dockendorff made 1 insider transaction in Haemonetics Corp (HAE) with a net sale of 10,215. Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 17,354 shares made by Stewart W Strong , a net sale of 9,129 shares made by Anila Lingamneni , and a net sale of 16,652 shares made by Michelle L Basil .

In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,857 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,857 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Charles J Dockendorff Mailing Address

Above is the net worth, insider trading, and ownership report for Charles J Dockendorff. You might contact Charles J Dockendorff via mailing address: Covidien Ltd., 15 Hampshire Street, Mansfield Ma 02048.